Georgia's Online Cancer Information Center

Survivorship Care Plans & Treatment Summaries

In a 2005 report entitled “From Cancer Patient to Cancer Survivor: Lost in Transition”, the Institute of Medicine (IOM) highlighted the need for more coordinated care as cancer survivors transition from active treatment with an oncologist to follow-up care with a primary care provider. In this report, the IOM recommended that all cancer survivors receive a Survivorship Care Plan (SCP) and Treatment Summary (TS).

SCPs and TSs are effective tools that provide a summary of a cancer survivor’s unique treatment as well as a tailored course of action for future healthcare needs. SCPs and TSs can empower both the cancer survivor and primary care provider with the knowledge and recommendations needed to offer the highest quality of care post- treatment.

In its 2012 Program Standards, the American College of Surgeons Commission on Cancer (CoC) stated that all CoC-accredited facilities would be required to deliver SCPs and TSs to their cancer survivors by 2015. To help CoC hospitals in Georgia reach this goal, the Georgia Cancer Control Consortium Survivorship Work Group has created objectives in the state’s Comprehensive Cancer Control Plan focused on increasing access to SCPs and TSs for cancer survivors in the state.

Several templates for SCPs and TSs currently exist, including Journey ForwardOncolifeASCO Treatment Summaries and Survivorship Care Plans, and the Pearlman Survivorship Kit. These can also be adapted to the unique needs of your practice.

Pearlman Survivorship Toolkit

Last Updated: 8/27/2021 1:52:06 PM

For Healthcare Professionals

Survivorship

Alabama embryo ruling may have devastating effect on cancer patients

Cancer patients concerned about their fertility and oncologists are expressing shock and anxiety about the recent ruling by the Alabama Supreme Court that frozen embryos are considered children under the law.

3/05/2024

Georgia CORE awards Cancer Research Fund grant to two teams

Georgia CORE has awarded two teams a Collaborative Cancer Research Seed Grant from the Georgia Cancer Research Fund.

5/10/2024